about
Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancyThe utility of circulating LHCGR as a predictor of Down's syndrome in early pregnancy.Ischemic stroke recurrence during pregnancy: a case series and a review of the literature.Stroke during pregnancy and pre-eclampsia.Endometriosis in a rural remote setting: a cross-sectional study.Prenatal ultrasound factors and genetic disorders in pregnancies complicated by polyhydramnios.Depleted mitochondrial DNA content in peripheral blood of women with a history of HELLP syndrome.Increased secretory sphingomyelinase activity in the first trimester of pregnancy in women later developing preeclampsia: a nested case-control study.Prenatal ultrasound predictors of postnatal major cerebral abnormalities in fetuses with apparently isolated mild ventriculomegaly.Predicting factors for emergency peripartum hysterectomy in women with placenta previa.Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.Placental findings in late-onset SGA births without Doppler signs of placental insufficiency.First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors.A role for mitochondria in gestational diabetes mellitus?Added value of umbilical vein flow as a predictor of perinatal outcome in term small-for-gestational-age fetuses.Predictive factors for neonatal survival in women with periviable preterm rupture of the membranes.Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester.Angiogenic Factors and Doppler Evaluation in Normally Growing Fetuses at Routine Third-Trimester Scan: Prediction of Subsequent Low Birth Weight.Performance of third-trimester combined screening model for prediction of adverse perinatal outcome.Psychological impact of first-trimester prevention for preeclampsia on anxiety.Confined placental mosaicism at chorionic villous sampling: risk factors and pregnancy outcome.The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome.Angiogenic factors vs Doppler surveillance in the prediction of adverse outcome among late-pregnancy small-for- gestational-age fetuses.First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler.First-trimester screening with specific algorithms for early- and late-onset fetal growth restriction.Contingent versus routine third-trimester screening for late fetal growth restriction.An integrated model with classification criteria to predict small-for-gestational-age fetuses at risk of adverse perinatal outcome.Validation of a first-trimester screening model for pre-eclampsia in an unselected population.Changes in uterine artery Doppler velocimetry and circulating angiogenic factors in the first half of pregnancies delivering a small-for-gestational-age neonate.Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.Forms of Circulating Luteinizing Hormone Human Chorionic Gonadotropin Receptor for the Prediction of Early and Late Preeclampsia in the First Trimester of Pregnancy.Levels of maternal serum angiogenic factors in third-trimester normal pregnancies: reference ranges, influence of maternal and pregnancy factors and fetoplacental Doppler indices.Differential performance of first-trimester screening in predicting small-for-gestational-age neonate or fetal growth restriction.Obstetric risk factors for poor neonatal adaptation at birthCorrelation between histological signs of placental underperfusion and perinatal morbidity in late-onset small-for-gestational-age fetusesAssociation of Doppler parameters with placental signs of underperfusion in late-onset small-for-gestational-age pregnanciesNeurodevelopmental outcomes of near-term small-for-gestational-age infants with and without signs of placental underperfusionAngiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusionMetabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and fetuses with intrauterine growth restrictionAuthor's reply regarding “Confined placental mosaicism at chorionic villous sampling: risk factors and pregnancy outcome”
P50
Q33581738-3A487080-73E4-4FC5-A4B2-9271128D0651Q33770074-AE312D70-9E55-4C31-81BF-981D943CE79EQ38006612-8D1EB417-CB79-46A6-8582-A76B5342C609Q38152690-4CB52DD8-685E-46CA-86EE-3C5D0BED52E4Q38868035-6ACE1628-F186-48AA-A125-85927111AB19Q40725597-57F9F894-4A0E-4BE2-A55A-F7E4E902C065Q40803673-EDAB44F5-E1ED-4C15-BE23-94B4C85467D5Q40984472-A6ECA1CE-762E-40A2-B11B-1362146E5824Q41032059-68212D93-F4E2-4492-A168-85BFE6045C85Q41980363-BF4B657F-B950-45E2-8CBF-8579B494E88AQ43435201-0DA11757-1FE7-4DD4-A576-8B68E2948395Q43515209-6E90A2EC-D0BC-44F0-A405-AB3E6EAEC50BQ43620907-6E8AD631-3761-473E-95B0-BF7361307FACQ44890093-7E0664C7-44DB-41F6-82E3-68818F9AFC66Q44927970-63B0DFD5-10CE-4E54-B0F5-1BBB2A9CB042Q46419777-6E3B5F13-753D-4D82-8DB0-07D71CB039BBQ47248767-D1B0B85D-1722-4206-937D-4ED9338F282EQ47357957-D5E48876-401E-4EE9-B275-7EAA0F06E3AAQ47806176-2F84D8F1-0B44-4937-A037-5554469418BFQ47824580-83D00693-47B2-4844-8EA7-1874098A8FB9Q47831468-7D7BE438-8C01-49E1-B0F5-60D68D6CF55FQ49177600-1BC37743-7B60-496B-BEB0-AA4A00103CEBQ50483761-926CC486-72A2-4E02-96C7-ECCCD43C5B38Q50489891-3F6F95C7-E706-41CF-B586-D1A3F12DC5EFQ50719310-B03C58D4-1291-4FD5-B92B-8AAE52CF848AQ50936123-45FBDA2D-E8AF-4876-AE27-159127ABFD4CQ51018184-494BE27C-E864-4F76-932D-5FB9B4423E9AQ51722856-7384E1CD-241B-405C-AA6F-9C8F0D523ABDQ51729764-94F8682D-9F17-4559-9432-AB8FD0E813B8Q53092224-0CC28E49-DAE1-4FA4-ACBD-7CA42590785BQ54290884-FDA9E591-ECCC-4188-A281-8D7488AF7C49Q54346737-CB29FC3D-C745-4EC8-A9EC-831900167F1AQ55026595-AC5395A9-3C7C-4EC7-BBB5-458A0B5DAF4AQ57009879-97F4785D-5AE9-4785-BDEC-6FD722F1BE8BQ57316839-92FDC461-84DF-4CA2-9000-280C59D1971DQ57316846-E70D34E6-17C3-4B1C-ACDF-69292C10F5A0Q57316847-51849D68-CF34-422B-A558-40C04629ED40Q57316850-9A5AB528-F31C-4298-89B8-D44142A9AF29Q58751731-E63EF665-5CCC-40CB-9130-4DD4EBD98D14Q61855495-42F8F935-4EA3-4B15-9B27-8F54C7B8D21D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
F Crovetto
@ast
F Crovetto
@en
F Crovetto
@es
F Crovetto
@nl
type
label
F Crovetto
@ast
F Crovetto
@en
F Crovetto
@es
F Crovetto
@nl
prefLabel
F Crovetto
@ast
F Crovetto
@en
F Crovetto
@es
F Crovetto
@nl
P106
P31
P496
0000-0003-0140-7411